|
🐜
|
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs
8 auth.
G. Reid,
P. Wielinga,
N. Zelcer,
Ingrid van der Heijden,
A. Kuil,
M. de Haas,
...
J. Wijnholds,
P. Borst
|
9 |
2003 |
9
🐜
|
|
🐜
|
Loss of p53 triggers Wnt-dependent systemic inflammation to drive breast cancer metastasis
20 auth.
M. Wellenstein,
S. Coffelt,
D. Duits,
M. V. van Miltenburg,
M. Slagter,
Iris de Rink,
L. Henneman,
S. Kas,
S. Prekovic,
Cheei-Sing Hau,
...
K. Vrijland,
Anne Paulien Drenth,
Renske de Korte-Grimmerink,
Eva Schut,
Ingrid van der Heijden,
W. Zwart,
L. Wessels,
T. Schumacher,
J. Jonkers,
K. D. de Visser
|
8 |
2019 |
8
🐜
|
|
🐜
|
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
13 auth.
S. Rottenberg,
A. Nygren,
M. Pajic,
F. V. van Leeuwen,
Ingrid van der Heijden,
K. van de Wetering,
Xiaoling Liu,
K. D. de Visser,
K. Gilhuijs,
O. van Tellingen,
...
J. Schouten,
J. Jonkers,
P. Borst
|
8 |
2007 |
8
🐜
|
|
🐜
|
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
7 auth.
N. Zelcer,
G. Reid,
P. Wielinga,
A. Kuil,
Ingrid van der Heijden,
J. Schuetz,
...
P. Borst
|
8 |
2003 |
8
🐜
|
|
🐬
|
Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells*
P. Wielinga,
Ingrid van der Heijden,
G. Reid,
J. Beijnen,
J. Wijnholds,
P. Borst
|
8 |
2003 |
8
🐬
|
|
🐜
|
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.
16 auth.
R. Drost,
P. Bouwman,
S. Rottenberg,
U. Boon,
Eva Schut,
S. Klarenbeek,
C. Klijn,
Ingrid van der Heijden,
H. van der Gulden,
E. Wientjens,
...
Mark Pieterse,
A. Catteau,
Peter M. Green,
E. Solomon,
Joanna R. Morris,
J. Jonkers
|
8 |
2011 |
8
🐜
|
|
🐜
|
Edinburgh Research Explorer The BRCA1-11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.
38 auth.
Yifan Wang,
Andrea J. Bernhardy,
C. Cruz,
J. Krais,
Joseph Nacson,
E. Nicolas,
S. Peri,
H. van der Gulden,
Ingrid van der Heijden,
S. O’Brien,
Yong Zhang,
Maribel I Harrell,
Shawn F. Johnson,
F. J. Candido dos Reis,
P. Pharoah,
...
B. Karlan,
C. Gourley,
D. Lambrechts,
G. Chenevix-Trench,
Hampus Olsson,
J. Benítez,
M. Greene,
M. Gore,
R. Nussbaum,
S. Sadetzki,
S. Gayther,
S. K. Kjaer,
A. D’Andrea,
G. Shapiro,
D. Wiest,
D. Connolly,
M. Daly,
E. Swisher,
P. Bouwman,
J. Jonkers,
J. Balmaña,
V. Serra,
N. Johnson
|
7 |
2018 |
7
🐜
|
|
🐜
|
A high-throughput functional complementation assay for classification of BRCA1 missense variants.
11 auth.
P. Bouwman,
H. van der Gulden,
Ingrid van der Heijden,
R. Drost,
C. Klijn,
P. Prasetyanti,
...
Mark Pieterse,
E. Wientjens,
Jost Seibler,
F. Hogervorst,
J. Jonkers
|
7 |
2013 |
7
🐜
|
|
🐜
|
The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.
14 auth.
P. Wielinga,
J. H. Hooijberg,
S. Gunnarsdottir,
I. Kathmann,
G. Reid,
N. Zelcer,
K. van der Born,
M. de Haas,
Ingrid van der Heijden,
G. Kaspers,
...
J. Wijnholds,
G. Jansen,
G. Peters,
P. Borst
|
6 |
2005 |
6
🐜
|
|
🐜
|
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.
29 auth.
R. Drost,
Kiranjit K. Dhillon,
H. van der Gulden,
Ingrid van der Heijden,
I. Brandsma,
C. Cruz,
Dafni Chondronasiou,
Marta Castroviejo-Bermejo,
U. Boon,
Eva Schut,
Eline van der Burg,
E. Wientjens,
Mark Pieterse,
C. Klijn,
S. Klarenbeek,
...
Fabricio Loayza-Puch,
Ran Elkon,
L. van Deemter,
S. Rottenberg,
M. van de Ven,
D. Dekkers,
Jeroen A. A. Demmers,
D. V. van Gent,
R. Agami,
J. Balmaña,
V. Serra,
T. Taniguchi,
P. Bouwman,
J. Jonkers
|
6 |
2016 |
6
🐜
|
|
🐜
|
cGMP transport by vesicles from human and mouse erythrocytes
11 auth.
C. D. de Wolf,
H. Yamaguchi,
Ingrid van der Heijden,
P. Wielinga,
Stefanie L. Hundscheid,
Nobuhito Ono,
...
G. Scheffer,
M. de Haas,
J. Schuetz,
J. Wijnholds,
P. Borst
|
6 |
2007 |
6
🐜
|
